Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 8, No 4 (2012) UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES Abstract  similar documents
N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina
"... components according to multifactor origin of cardiovascular disease (CVD). Correction of lipid metabolism ..."
 
Vol 10, No 1 (2014) MULTIFACTOR PRIMARY PREVENTION OF ISCHEMIC HEART DISEASE IN MIDDLE-AGED MEN AND ITS EFFICACY (10-YEAR FOLLOW-UP) Abstract  PDF (Eng)  similar documents
A. M. Kalinina
"... primary prevention of atherosclerosis-mediated cardiovascular diseases. Primary medical prevention has ..."
 
Vol 9, No 3 (2013) STATINS AND RISK OF INFECTIOUS DISEASES Abstract  similar documents
O. M. Drapkina, R. N. Shepel'
"... , and pneumonia particularly. Results of the large studies on statin influence on infectious disease are presented. ..."
 
Vol 5, No 3 (2009) CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE Abstract  PDF (Eng)  similar documents
I. E. Sapozhnikova, E. I. Tarlovskaya, E. N. Anufrieva
"... Aim. To evaluate cardiovascular diseases (CVD) treatment in patients with type 2 diabetes mellitus ..."
 
Vol 12, No 4 (2016) Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk Abstract  similar documents
O. M. Drapkina, O. N. Korneeva
"... for a number of cardiovascular diseases (CVD), is considered. The high prevalence of cardiovascular risk ..."
 
Vol 7, No 6 (2011) DETERMINANTS OF PREVENTIVE BEHAVIOR REGARDING CARDIOVASCULAR DISEASES AND RISK FACTORS IN PATIENTS WITH ESSENTIAL HYPERTENSION AND CHRONIC ISCHEMIC HEART DISEASE Abstract  similar documents
D. Yu. Platonov, T. A. Kostjuk, A. I. Brandt, O. V. Tsygankova
"... logistic regression. Results. Awareness of the cardiovascular diseases (CVD) and its prevention (odds ratio ..."
 
Vol 9, No 2 (2013) STATIN SAFETY REVISITED DATA Abstract  similar documents
O. M. Drapkina
"... Questions of statins use in liver diseases are discussed. Data from clinical studies on statins ..."
 
Vol 5, No 2 (2009) DOCTOR INERTNESS AS A FACTOR DISTURBING EFFECTIVE TREATMENT OF CARDIOVASCULAR DISEASES Abstract  similar documents
E. V. Minakov, R. A. Khokhlov, G. I. Furmenko, N. M. Akhmedzhanov
"... which treat and follow-up patients with cardiovascular diseases (CVD). Material and methods ..."
 
Vol 12, No 5 (2016) The Value of Subclinical Carotid Atherosclerosis for Primary Prevention of Cardiovascular Diseases. Review of the Main International Studies Abstract  similar documents
E. K. Butina, E. V. Bochkareva
"... Measures for the prevention of cardiovascular diseases (CVD) are more effective ..."
 
Vol 9, No 4 (2013) STATINS IN PREVENTION OF ISCHEMIC STROKE Abstract  similar documents
A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk
"... The evidence base of statin therapy in primary and secondary prevention of ischemic stroke ..."
 
Vol 11, No 2 (2015) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT? Abstract  similar documents
S. Yu. Martsevich, O. V. Lerman, N. P. Kutishenko, A. Yu. Suvorov
"... the possibility of statins prescription to patients with cardiovascular disease if they have concomitant liver ..."
 
Vol 14, No 5 (2018) Drug Therapy Structure and Clinical Characteristics of Patients with Atrial Fibrillation According to Data of REKUR-AF Study Abstract  similar documents
I. L. Polshakova, S. V. Povetkin
"... data, the type and duration of AF, cardiovascular diseases (CVD), concomitant noncardiac pathology ..."
 
Vol 10, No 2 (2014) STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov
"... in patients with cardiovascular diseases (CVD) and high risk of cardiovascular events (CVE) with indications ..."
 
Vol 5, No 1 (2009) CARDIOLOGICAL MANAGEMENT OF PREGNANT WOMEN IN THE UDMURT REPUBLIC Abstract  similar documents
I. R. Gaisin, R. M. Valeeva, L. V. Shilina, N. Yu. Chernisheva, N. I. Maksimov
"... diseases (CVD) in the Udmurt Republic (UR) of Russia. Material and methods. In prospective ..."
 
Vol 10, No 5 (2014) STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE Abstract  similar documents
L. N. Malay
"... for the treatment and prevention of cardiovascular diseases caused by atherosclerosis. The milestones of lipid ..."
 
Vol 15, No 2 (2019) Detectability of Subclinical Hypothyroidism and Thyroid Stimulating Hormone Levels Associated with Cardiovascular Diseases in Patients of North-West Region Hospital Abstract  similar documents
A. R. Volkova, O. D. Dygun, O. N. Zhdanova, B. G. Lukichev, L. A. Belyakova, E. M. Sereda
"... with cardiovascular diseases (CVD) is an important clinical task. Aim. To study the detectability of subclinical ..."
 
Vol 12, No 3 (2016) REPORT ON THE ROUND-TABLE MEETING: "REGISTERS IN CARDIOLOGY: THE BASIC RULES OF MANAGEMENT, MODERN EXPERIENCE AND THE RESULTS OF THEIR CREATION IN THE VARIOUS REGIONS OF THE RUSSIAN FEDERATION" Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, M. M. Loukianov, N. P. Kutishenko
"... of various cardiovascular diseases (CVD) were among participants of the meeting. The importance of modern ..."
 
Vol 14, No 2 (2018) ECONOMIC BURDEN OF CARDIOVASCULAR DISEASES IN THE RUSSIAN FEDERATION IN 2016 Abstract  PDF (Eng)  similar documents
A. N. Kontsevaya, O. M. Drapkina, Yu. A. Balanova, A. E. Imaeva, E. I. Suvorova, M. B. Khudyakov
"... Aim. To evaluate the economic burden of cardiovascular diseases (CVD) in the Russian Federation ..."
 
Vol 11, No 5 (2015) Excess winter cardiovascular morbidity in Ivanovo Region in 2009-2013 years Abstract  similar documents
A. V. Kontsevaya, J. A. Balanova, M. M. Loukianov, M. B. Khudyakov, O. A. Belova, S. V. Romanchuk
"... . The incidence of cardiovascular diseases (CVDs) was determined according to the data from the medical ..."
 
Vol 15, No 3 (2019) Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 2. Association of Breast Arterial Calcification and Cardiovascular Diseases Abstract  similar documents
E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina
"... with the prevalence and mortality from cardiovascular diseases (CVD). The presence of BAC on mammograms is associated ..."
 
Vol 10, No 6 (2014) VALIDATION OF THE MACNEW QUESTIONNAIRE FOR THE ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ISHEMIC HEART DISEASE Abstract  PDF (Eng)  similar documents
N. V. Pogosova, A. A. Kursakov, I. H. Boycharov, S. Höfer, N. Oldridge
"... ) in both global and Russian practice. In many countries HRQL in patients with ischemic heart disease (IHD ..."
 
Vol 14, No 6 (2018) Cardiovascular Diseases and Drug Treatment in Patients with the History of Cerebral Stroke: Data of the Outpatient Registry REGION Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, O. M. Drapkina, A. N. Vorobyev, A. V. Zagrebelnyy, A. N. Kozminsky, K. A. Moseichuk, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Okshina, E. V. Kudryashov, E. N. Belova, V. G. Klyashtorny, S. A. Boytsov
"... Aim. To evaluate the structure of combined cardiovascular diseases, drug treatment and observation ..."
 
Vol 11, No 5 (2015) The role of peptide hormones (adiponectin, leptin, insulin) in the pathogenesis of atherosclerosis Abstract  similar documents
S. A. Smetnev, A. N. Meshkov
"... Currently, cardiovascular diseases (CVD) remain the main problem in the world and in Russia ..."
 
Vol 5, No 6 (2009) STATIN GENERICS: EFFICACY AND SAFETY RATIO Abstract  similar documents
V. P. Voronina, A. A. Serazhim, A. V. Zagrebelnyi, S. Yu. Martsevich, S. A. Shalnova
"... Statin usage for primary and secondary prevention of cardiovascular diseases is focused. Rational ..."
 
Vol 12, No 3 (2016) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA? Abstract  PDF (Eng)  similar documents
S. N. Bel'diev
"... to use statins in patients with cardiovascular diseases and concomitant chronic liver diseases. Analysis ..."
 
Vol 10, No 5 (2014) OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov
"... cardiovascular surgery. There were 63 hospitalizations due to cardiovascular diseases (CVD). AF did not lead ..."
 
Vol 12, No 1 (2016) CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, N. N. Nikulina, K. G. Pereverzeva, E. A. Pravkina, A. D. Deev, E. V. Kudryashov, E. N. Belova
"... Aim. To study a pattern of concomitant cardiovascular diseases (CVDs) and to estimate ..."
 
Vol 9, No 2 (2013) MEDICAL SUPERVISION IN SPECIALIZED CENTER AND THE QUALITY OF LIPID-LOWERING THERAPY IN PATIENTS WITH CARDIOVASCULAR DISEASES (ACCORDING TO THE PROFIL REGISTER) Abstract  similar documents
S. Yu. Martsevich, O. V. Gaysenok, S. G. Tripkosh, A. V. Zagrebelnyy, Yu. V. Lukina
"... register are used. All patients having cardiovascular diseases, high cardiovascular risk, and seeking ..."
 
Vol 14, No 6 (2018) Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation Abstract  PDF (Eng)  similar documents
A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee
"... diseases (CVD) in several regions of the Russian Federation with different climatic, geographic, economic ..."
 
Vol 15, No 2 (2019) Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 1. Breast Arterial Calcification: Pathomorphology, Prevalence and Risk Factors Abstract  similar documents
E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina
"... with cardiovascular diseases (CVD). This allows it to be considered as a new marker of cardiovascular risk in women ..."
 
Vol 14, No 4 (2018) Role of Gut Microbiota in the Pathogenesis of Cardiovascular Diseases and Metabolic Syndrome Abstract  similar documents
O. M. Drapkina, O. E. Shirobokikh
"... The role of gut microbiota in the pathogenesis of cardiovascular diseases (CVD) and metabolic ..."
 
Vol 10, No 4 (2014) DIAGNOSTICS, TREATMENT, ASSOCIATED CARDIOVASCULAR AND CONCOMITANT NON-CARDIAC DISEASES IN PATIENTS WITH DIAGNOSIS OF “ATRIAL FIBRILLATION” IN REAL OUTPATIENT PRACTICE (ACCORDING TO DATA OF REGISTRY OF CARDIOVASCULAR DISEASES, RECVASA) Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov
"... of CardioVAScular diseAses (RECVASA). 530 of 3690 (14.4%) patients had the "atrial fibrillation" diagnosis ..."
 
Vol 4, No 1 (2008) ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
"... The main indications to statins and principles of statin usage on the basis of International ..."
 
Vol 5, No 4 (2009) PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
"... The definition of primary prevention of cardiovascular diseases is presented. Statins preventive ..."
 
Vol 13, No 3 (2017) SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION Abstract  similar documents
S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev
"... Aim. To study secondary prevention of cardiovascular diseases among patients of different age ..."
 
Vol 8, No 5 (2012) HIGH HEART RATE AS A POTENTIAL RISK FACTOR FOR DEVELOPMENT OF CARDIOVASCULAR DISEASES IN WOMEN WITH RHEUMATOID ARTHRITIS Abstract  similar documents
D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov
"... diseases (TRF for CVD), subclinical structural and functional changes in the heart and vessels, as well ..."
 
Vol 1, No 3 (2005) RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS Abstract  similar documents
D. A. Anichkov, N. A. Shostak
"... The cardiovascular risk factors in patients with rheumatoid arthritis (RA) are reviewed ..."
 
Vol 12, No 3 (2016) CORRELATIONS OF DIFFERENT STRUCTURAL AND FUNCTIONAL CHARACTERISTICS OF ARTERIAL WALL WITH TRADITIONAL CARDIOVASCULAR RISK FACTORS IN HEALTHY PEOPLE OF DIFFERENT AGE. PART 2 Abstract  PDF (Eng)  similar documents
I. D. Strazhesko, O. N. Tkacheva, D. U. Akasheva, E. V. Dudinskaya, M. V. Agaltsov, A. S. Kruglikova, N. V. Brailova, V. S. Pykhtina, E. V. Plokhova, N. V. Sharashkina, O. Yu. Isaykina, V. A. Vygodin, S. A. Boytsov
"... of effective cardiovascular disease (CVD) primary prevention. Such lesions include: arterial wall thickening ..."
 
Vol 14, No 6 (2018) Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues Abstract  PDF (Eng)  similar documents
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan
"... on the correction of dyslipidemia in patients with proven atherosclerosis-related cardiovascular diseases as well ..."
 
Vol 15, No 1 (2019) Factors Associated with Cause-Specific Death in Russia. Data from Longitudinal Prospective Study 1977-2001 Abstract  PDF (Eng)  similar documents
S. A. Shalnova, A. V. Kapustina, A. D. Deev, Yu. A. Balanova
"... and their associations with cause-specific mortalities: coronary heart disease (CHD), stroke, cardiovascular diseases ..."
 
Vol 10, No 5 (2014) STATINS USE IN THE PERIOPERATIVE PERIOD ACCORDING TO THE EVIDENCE-BASED MEDICINE Abstract  similar documents
V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev
"... in patients with cardiovascular diseases to reduce the risk of cardiac complications in the perioperative ..."
 
Vol 14, No 5 (2018) Economic losses due to low coverage of lipid-lowering therapy in patients with cardiovascular diseases in the Russian Federation Abstract  similar documents
Yu. A. Balanova, A. V. Kontsevaya, A. E. Imaeva, O. I. Karpov, M. B. Khudyakov
"... ) in patients with cardiovascular diseases (CVD) and hypercholesterolemia (HCS) in the Russian population ..."
 
Vol 14, No 5 (2018) Effect of Previous Cardiovascular Diseases on Long-Term Outcomes of Acute Myocardial Infarction: Data of the Outpatient Registry "PROFILE-IM” Abstract  similar documents
N. P. Kutishenko, D. P. Sichinava, E. P. Kalaydzhyan, V. A. Evdakov, E. A. Kasparova, S. Yu. Martsevich
"... (AMI), to assess the influence of factors in medical history, especially cardiovascular diseases (CVD ..."
 
Vol 11, No 3 (2015) THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov
"... with statins and UDCA is effective and safe in patients with high cardiovascular risk and concomitant liver ..."
 
Vol 9, No 1 (2013) OUTPATIENT REGISTER OF CARDIOVASCULAR DISEASES IN THE RYAZAN REGION (RECVASA): PRINCIPAL TASKS, EXPERIENCE OF DEVELOPMENT AND FIRST RESULTS Abstract  PDF (Eng)  similar documents
S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, M. M. Lukyanov, N. N. Nikulina, A. V. Zagrebelny, A. N. Vorobyov, K. G. Pereverseva, E. A. Pravkina, A. D. Deev, E. Yu. Andreenko, A. I. Ershova, A. N. Meshkov, R. P. Myasnikov, S. E. Serdyuk, М. S. Kharlap
"... Aim. To estimate risk factors and comorbidity structure, cardiovascular diseases outcomes ..."
 
Vol 13, No 4 (2017) PATIENTS WITH ATRIAL FIBRILLATION IN MULTIDISCIPLINARY HOSPITAL: STRUCTURE OF HOSPITALIZATION, CONCOMITANT CARDIOVASCULAR DISEASES AND DRUG TREATMENT (DATA OF RECVASA AF-TULA REGISTRY) Abstract  similar documents
M. N. Valiakhmetov, T. A. Gomova, M. M. Loukianov, S. Yu. Martsevich, K. N. Nadejkina, M. N. Artemova, D. N. Jilin, E. E. Fedotova, A. V. Zagrebelnyy, E. V. Kudryashov, S. A. Boytsov
"... cardiovascular diseases (CVD) and drug therapy within the RECVAZA AF-Tula hospital registry. Material ..."
 
Vol 12, No 2 (2016) CORRELATIONS OF DIFFERENT STRUCTURAL AND FUNCTIONAL CHARACTERISTICS OF ARTERIAL WALL WITH TRADITIONAL CARDIOVASCULAR RISK FACTORS IN HEALTHY PEOPLE OF DIFFERENT AGE. PART 1 Abstract  PDF (Eng)  PDF (Eng)  similar documents
I. D. Strazhesko, O. N. Tkacheva, D. U. Akasheva, E. V. Dudinskaya, M. V. Agaltsov, A. S. Kruglikova, N. V. Brailova, V. S. Pykhtina, E. V. Plokhova, N. V. Sharashkina, O. Yu. Isaykina, V. A. Vygodin, S. A. Boytsov
"... for cardiovascular disease (CVD) grows. The nature of relationship between these indices in people without CVD ..."
 
Vol 1, No 1 (2005) TOBACCO DEPENDENCE TREATMENT WITH NICOTINE REPLACEMENT THERAPY AS ONE OF THE METHODS FOR CARDIOVASCULAR DISEASE RISK REDUCTION Abstract  similar documents
O. V. Vikhireva, S. A. Shalnova, A. D. Deev
"... to quit smoking. To assess expected reduction of cardiovascular disease (CVD) and total mortality relative ..."
 
Vol 11, No 4 (2015) TREATMENT OF PATIENTS WITH SEVERE DYSLIPIDEMIA IN REAL CLINICAL PRACTICE Abstract  similar documents
V. A. Korneva, T. Yu. Kuznetsova, E. S. Karpova, K. I. Rupasova
"... Cardiovascular diseases remain the most common cause of death in Russia. In real clinical practice ..."
 
Vol 11, No 2 (2015) HYPOLIPIDEMIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN 2004-2010 ACCORDING TO THE PROGNOZ IBS REGISTER Abstract  similar documents
S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich
"... Aim. To evaluate the frequency of prescription, efficacy and patients adherence to statin therapy ..."
 
Vol 13, No 4 (2017) OCCURRENCE OF THE METABOLIC SYNDROME AND ITS EFFECT ON CARDIOVASCULAR RISK IN PATIENTS WITH GOUT Abstract  similar documents
I. I. Polskaya, I. M. Marusenko, T. I. Kulagina, N. N. Vezikova
"... Aim. To study the prevalence of metabolic syndrome (MS) and total risk of cardiovascular diseases ..."
 
Vol 8, No 6 (2012) THE RELATIONSHIP OF CARDIOVASCULAR RISK FACTORS AND ARTERIAL WALL STIFFNESS IN WOMEN WITH A HIGH ACTIVITY OF RHEUMATOID ARTHRITIS Abstract  similar documents
D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov
"... ) of cardiovascular disease (CVD), duplex scanning of the common carotid arteries, transthoracic echocardiography ..."
 
Vol 12, No 5 (2016) Endothelium Protective Function of Statins in Men and Women with Coronary Atherosclerosis Abstract  similar documents
M. V. Klimushina, N. G. Gumanova, A. Ju. Gorshkov, N. E. Gavrilova, V. A. Metel'skaja, S. A. Boytsov
"... . Negative correlation between the statins receiving and serum endothelin level was found in men (r=-0.11; p ..."
 
Vol 13, No 4 (2017) CLINICAL PRACTICE OF BETA-BLOCKERS USAGE IN PATIENTS WITH CARDIOVASCULAR AND CHRONIC RESPIRATORY DISEASES. DATA OF OUTPATIENT REGISTRIES PROFILE AND RECVASA Abstract  similar documents
S. Yu. Martsevich, N. A. Zakharova, N. P. Kutishenko, A. V. Zagrebelnyy, Yu. V. Lukina, M. M. Loukianov, A. N. Vorobyev, A. N. Kozminsky
"... diseases (CVD) in the presence of limitations (chronic obstructive pulmonary disease – COPD ..."
 
Vol 6, No 4 (2010) EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK Abstract  similar documents
N. V. Perova, E. I. Sokolov, G. N. Shchukina, V. A. Metelskaya
"... Current views on the efficacy criteria of hyperlipidaemia treatment with statins are considered ..."
 
Vol 8, No 5 (2012) LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS Abstract  similar documents
A. N. Meshkov
"... of the study of rosuvastatin therapy efficacy , in comparison with other statins, received in controlled ..."
 
Vol 6, No 4 (2010) HYPOANDROGEN CONDITION AND CARDIOVASCULAR DISEASES: ACTUAL QUESTIONS OF COMORBIDITY IN CLINICAL PRACTICE Abstract  similar documents
G. G. Sharvadze, D. G. Kurbatov, E. A. Poddubskaya, M. N. Mamedov
"... The correlation of age-dependent reduction in sex hormones level and changes of cardiovascular ..."
 
Vol 10, No 3 (2014) THE SAFETY OF STATINS: WHAT A PHYSICIAN NEEDS TO KNOW Abstract  similar documents
D. A. Napalkov
"... Various aspects of the safety of statins in clinical practice are discussed: hepatotoxicity ..."
 
Vol 12, No 3 (2016) EFFICACY AND SAFETY OF LIPID-LOWERING DRUGS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN THE ELDERLY Abstract  PDF (Eng)  similar documents
E. A. Ushkalova, O. N. Tkacheva, N. K. Runikhina, N. A. Chukhareva, A. Yu. Bevz
"... of cardiovascular diseases in patients ≥80 years of age who are the most quickly growing group of population ..."
 
Vol 5, No 1 (2009) CLINICAL SIGNIFICANCE OF HEART RATE VARIABILITY INDEXES DERIVED FROM 5-MINUTE AND 24-HOUR ECG RECORDINGS IN PATIENTS WITH RHEUMATOID ARTHRITIS Abstract  similar documents
D. A. Anichkov, A. A. Platonova
"... association between HRV indexes and cardiovascular risk factors and RA-related clinical characteristics ..."
 
Vol 13, No 1 (2017) SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION Abstract  similar documents
S. N. Bel'diev
"... Russian physicians often afraid to use statins in patients with high cardiovascular risk ..."
 
Vol 15, No 1 (2019) The Trends of Cardiovascular and Cancer Mortality in Russian Men and Women from 2000 to 2016 years Abstract  similar documents
S. A. Shalnova, O. M. Drapkina
"... coronary heart disease (CHD), cerebrovascular disease (CerVD), other CVD, and cancer, including prostate ..."
 
Vol 9, No 4 (2013) STATINS AND THE RISK OF DIABETES MELLITUS Abstract  similar documents
O. M. Drapkina
"... Randomized controlled trials have clearly demonstrated the efficacy of statins in reduction ..."
 
Vol 7, No 6 (2011) A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA Abstract  similar documents
V. P. Voronina, S. N. Tolpygina, N. P. Kutishenko, N. A. Dmitrieva, Yu. V. Lukina, S. Yu. Martsevich
"... - дечно-сосудистыми заболеваниями (ССЗ) оправдано тем, что они обладают наиболее выраженным и мощным ги ..."
 
Vol 13, No 4 (2017) GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS Abstract  similar documents
M. A. Vorobyeva, M. M. Azova, O. O. Gigani, I. V. Garmash, S. V. Villevalde, Zh. D. Kobalava
"... patients with a history of cardiovascular disease and low-density lipoprotein cholesterol (LDL-C)>1.8 mmol ..."
 
Vol 15, No 4 (2019) Evidence, Guidelines and Treatment Algorithms for Patients with Arterial Hypertension and Dyslipidemia: the Need for Compromise and Optimization of Tactics in Practical Healthcare Abstract  similar documents
O. M. Drapkina, M. V. Ezhov, S. R. Gilyarevsky, R. N Shepel
"... of cardiovascular complications for primary prevention in a wide population are presented. The question of the ratio ..."
 
Vol 6, No 6 (2010) COMPARATIVE EFFICACY OF THE STATINS IN PREVENTING AND TREATING OF THE CORONARY HEART DISEASE Abstract  similar documents
S. V. Shalaev, Z. M. Safiullina, L. V. Kremneva, O. V. Abaturova
"... forms of ischemic heart disease (IHD). Pleiotropic effects, in particular, effect on endothelial ..."
 
Vol 8, No 4 (2012) EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS Abstract  similar documents
I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze
"... and, first of all beta-blockers, ACE inhibitors, diuretics, and statins on bone are presented. Mode of action ..."
 
Vol 11, No 5 (2015) Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis Abstract  similar documents
N. E. Gavrilova, V. A. Metelskaya, E. B. Yarovaya, N. V. Gomyranova, S. A. Boytsov
"... Aim. To assess of lipid-lowering therapy with statins in very high cardiovascular risk patients ..."
 
Vol 10, No 6 (2014) DIAGNOSIS AND TREATMENT OF PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA IN REAL OUTPATIENT PRACTICE (ACCORDING TO THE RECVASA REGISTRY) Abstract  similar documents
A. I. Ershova, A. N. Meshkov, S. S. Yakushin, M. M. Loukianov, K. A. Moseychuk, S. Yu. Martsevich, A. V. Zagrebelnyy, A. N. Vorobyev, K. G. Pereverzeva, E. A. Pravkina, A. N. Kozminskiy, S. A. Boytsov
"... Hypercholesterolemia is a proven risk factor for atherosclerotic cardiovascular diseases ..."
 
Vol 10, No 4 (2014) STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN Abstract  similar documents
N. G. Gogolashvili
"... and other cardiovascular events in patients with percutaneous coronary intervention is discussed. ..."
 
Vol 11, No 3 (2015) ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I Abstract  similar documents
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, O. N. Tkacheva, A. S. Lishuta
"... Aim. To study the level of total cholesterol in patients at high and very high cardiovascular risk ..."
 
Vol 8, No 6 (2012) SECONDARY PHARMACOLOGICAL PREVENTION OF CARDIOVASCULAR DISEASES: OUR ABILITY IN CLINICAL PRACTICE Abstract  similar documents
E. V. Filippov, S. S. Yakushin
"... The most pressing issues of the secondary drug prevention of the most common cardiovascular ..."
 
Vol 4, No 4 (2008) BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST Abstract  similar documents
L. N. Malaj
"... Usage of β-blockers (BB) for treatment of patients with cardiovascular diseases is discussed ..."
 
Vol 12, No 1 (2016) Gut microbiota – a new companion on the path of cardiovascular diseases progression: surprising roles of long-time neighbors Abstract  similar documents
O. M. Drapkina, A. N. Kaburova
"... to chronic disease progression. The researchers’ careful attention is focused on improving the understanding ..."
 
Vol 5, No 3 (2009) RISK FACTORS OF THE ERECTILE DYSFUNCTION IN THE PATIENTS WITH CARDIOVASCULAR DISEASES Abstract  similar documents
E. V. Minakov, R. A. Khokhlov, T. N. Kuznetsova, Y. V. Popovskaya, D. V. Snustikov, E. E. Tsareva, V. I. Yarliykova, N. M. Akhmedzhanov
"... to provide high level of compliance in patients with cardiovascular diseases. ..."
 
Vol 6, No 4 (2010) ECONOMIC EFFICIENCY OF THE IMPLEMENTATION OF THE PROGRAM OF CARDIOVASCULAR DISEASES MULTIFACTORIAL PREVENTION IN THE ORGANIZED COLLECTIVE OF TECHNICAL RESEARCH INSTITUTE Abstract  similar documents
A. V. Kontsevaya, A. M. Kalinina, S. V. Belonosova, J. M. Pozdnjakov, M. B. Khudyakov
"... consultation. Costs associated with cardiovascular diseases and risk factors (medical care consumption ..."
 
Vol 13, No 2 (2017) SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova
"... prevention of cardiovascular diseases in patients with a history of myocardial infarction in ambulatory ..."
 
Vol 10, No 1 (2014) ARTERIAL STIFFNESS AND CHRONIC KIDNEY DISEASE: CAUSES AND CONSEQUENCES Abstract  similar documents
J. D. Kobalava, Yu. V. Kotovskaya, S. V. Villevalde, A. E. Soloveva, I. M. Amirbegishvili
"... Chronic kidney disease (CKD) is associated with increased cardiovascular risk. CKD ..."
 
Vol 6, No 1 (2010) THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE Abstract  similar documents
Yu. V. Lukina, S. Yu. Martsevich
"... Data of the evidence based medicine about bisoprolol treatment of patients with cardiovascular ..."
 
Vol 9, No 1 (2013) EFFECT OF DIFFERENT GLUCOSE BLOOD LEVELS ON THE DEVELOPMENT OF CARDIOVASCULAR DISEASES AND COMPLICATIONS Abstract  similar documents
E. V. Akhmedova, Z. A. Toguzova, M. N. Mamedov
"... growth rate of mortality. Glucose blood levels should be monitored to reduce the risk of cardiovascular ..."
 
Vol 12, No 3 (2016) PRACTICE OF PRESCRIBING BETA-BLOCKERS AND ITS COMPLIANCE WITH CLINICAL GUIDELINES ACCORDING TO TWO REGISTERS OF CARDIOVASCULAR DISEASES Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, N. A. Zakharova, N. P. Kutishenko, A. V. Zagrebelnyy, A. V. Zakharova, M. M. Loukianov, A. N. Vorobyev, K. A. Moseichuk, A. N. Kozminsky
"... frequently prescribed BB was bisoprolol in all cardiovascular diseases. Conclusion. In a specialized medical ..."
 
Vol 11, No 5 (2015) Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation Abstract  similar documents
E. V. Udachkina, D. S. Novikova, T. V. Popkova, E. Yu. Panasyuk, A. S. Avdeeva, A. V. Volkov, I. G. Kirillova, E. I. Markelova, E. N. Aleksandrova, A. A. Novikov, E. L. Nasonov
"... proatherogenic blood profile was observed in both groups. The patients of MTX group more frequently took statins ..."
 
Vol 15, No 1 (2019) Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength Abstract  similar documents
I. A. Skripnikova, N. A. Alikhanova, M. A. Kolchinа, M. A. Myagkova, O. V. Kosmatova
"... of cardiovascular drugs, such as statins, beta-blockers, ACE inhibitors, diuretics, calcium antagonists and nitrates ..."
 
Vol 9, No 4 (2013) REAL PRACTICE OF STATINS USE AND ITS DEPENDENCE ON FOLLOW-UP IN THE SPECIALIZED MEDICAL CENTRE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (ACCORDING TO THE PROFILE REGISTER) Abstract  similar documents
S. Yu. Martsevich, O. V. Gaisenok, S. G. Tripkosh, Yu. V. Lukina, A. V. Zagrebel’nyy
"... Aim. To analyze tactics of statins use in patients with high cardiovascular risk on the base ..."
 
Vol 13, No 3 (2017) ARTERIAL STIFFNESS AND CARDIOVASCULAR RISK FACTORS IN YOUNG MEN (41-44 YEARS) Abstract  PDF (Eng)  similar documents
O. Yu. Isaykina, V. B. Rozanov, E. Yu. Zvolinskaya, H. S. Pugoeva, A. A. Alexandrov
"... Aim. To study the relationship of individual cardiovascular risk factors with arterial stiffness ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES Abstract  similar documents
A. N. Meshkov
"... is - the lower risk of cardiovascular diseases and their complications are. Efficacy and safety of atorvastatin ..."
 
Vol 5, No 2 (2009) OBSERVATIONAL TRAILS IN LIPIDOLOGY Abstract  similar documents
S. A. Shalnova
"... and observational trails are presented. The trail data on statins efficacy and safety are held up as a model. ..."
 
Vol 12, No 1 (2016) Effect of magnesium on the cardiovascular system in women Abstract  PDF (Eng)  similar documents
E. A. Ulubieva, A. G. Avtandilov
"... Recent scientific data on the influence of magnesium on the cardiovascular and reproductive system ..."
 
Vol 13, No 1 (2017) THE STUDY "REGISTER OF PATIENTS AFTER ACUTE STROKE (REGION)". PART 2. OUTPATIENT PROSPECTIVE REGISTER OF PATIENTS AFTER ACUTE STROKE (ACCORDING TO THE RESULTS OF THE PILOT PHASE OF THE STUDY) Abstract  PDF (Eng)  similar documents
S. А. Boytsov, M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, L. V. Stakhovskaya, A. N. Vorobyev, A. V. Zagrebelnyy, N. P. Kutishenko, A. N. Kozminsky, K. A. Moseichuk, K. G. Pereverzeva, E. A. Pravkina, E. N. Belova, E. V. Kudryashov, A. D. Deev
"... , concomitant cardiovascular diseases (CVD) and noncardiac diseases were analyzed. We estimated accordance ..."
 
Vol 3, No 3 (2007) STRESS: WHAT WE ACTUALLY KNOW ABOUT THIS RISK FACTOR? Abstract  similar documents
R. G. Oganov, G. V. Pogosova
"... as models of working stress. Pathophysiological modes of interactions of stress and cardiovascular diseases ..."
 
Vol 3, No 4 (2007) GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES Abstract  similar documents
L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, K. Malmberg, S. Priori, J. Ostergren, J. Tuomilehto, I. Thrainsdottir
"... The Task Force on Diabetes and Cardiovascular diseases of the European Society of Cardiology ..."
 
Vol 3, No 4 (2007) COMMENTS ON GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES Abstract  similar documents
An. A. Alexandrov
"... Comments on Guidelines on diabetes, pre-diabetes, and cardiovascular diseases. ..."
 
Vol 6, No 6 (2010) NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION Abstract  similar documents
E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya
"... Background. Effects of statins on cardiovascular end points are well-known. To study the impact ..."
 
Vol 6, No 5 (2010) PHOSPHODIESTERASE-5 INHIBITORS USE IN PATIENTS WITH ERECTILE DYSFUNCTION AND CARDIOVASCULAR DISEASE IN CLINICAL PRACTICE Abstract  similar documents
M. N. Mamedov, G. G. Sharvadze, E. A. Poddubsky, A. K. Ausheva
"... of ED in the majority of men (about 80% of patients) is cardiovascular diseases (atherosclerosis ..."
 
Vol 8, No 5 (2012) ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE? Abstract  similar documents
S. A. Boldueva, I. A. Leonova
"... and the main indications are discussed. ASA use for primary cardiovascular diseases prevention and its possible ..."
 
Vol 7, No 4 (2011) METHODS OF ASSISTANCE FOR SMOKING CESSATION IN INTERNATIONAL CLINICAL RECOMMENDATIONS FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASE Abstract  similar documents
M. S. Berezhnova
"... of cardiovascular disease. There are a lot of approaches to drop smoking including innovative pharmacotherapy ..."
 
Vol 10, No 5 (2014) RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME Abstract  similar documents
N. V. Perova, V. A. Metelskaya
"... Approaches to the total cardiovascular risk calculation based on the actual clinical ..."
 
Vol 7, No 3 (2011) POTASSIUM INTAKE, STROKE, AND CARDIOVASCULAR DISEASE: A META-ANALYSIS OF PROSPECTIVE STUDIES  similar documents
L. D'Elia, G. Barba, F. P. Cappuccio, P. Strazzullo
"... -сосудистых заболеваний (ССЗ). Введение. Cвязь между привычным потреблением калия и частотой сосудистых ..."
 
Vol 5, No 6 (2009) STATINS AND URSODEOXYCHOLIC ACID: COOPERATION OR NEUTRALITY? Abstract  similar documents
I. N. Grigorieva, Y. M. Pozdnyakov
"... Results of combined therapy of gallstone disease (GSD), non-alcoholic fatty liver disease (NAFLD ..."
 
1 - 100 of 1172 Items 1 2 3 4 5 6 7 8 9 10 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)